Ionis Pharmaceuticals | IONS - Fremdkapital





Fremdkapital Veränderung Datum
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Astellas Pharma JPY 320B 0 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Divis Laboratories Ltd INR 20M 0 2025-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 610M 584M 2025-12
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Omeros USD 403.72M 27.2M 2024-06
OPKO Health USD 337.11M 2.31M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 57.41B 93M 2025-09
Pharma Mar EUR 36.68M 1.07M 2025-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tilray USD 268.59M 3.82M 2025-09
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09